Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Pharmaceuticals & Biotech
/
Little Green Pharma
Create a narrative
Little Green Pharma Community
ASX:LGP Community
1
Narratives
written by author
1
Comments
on narratives written by author
44
Fair Values set
on narratives written by author
Community Investing Ideas
Little Green Pharma
Popular
Undervalued
Overvalued
Little Green Pharma
BA
Babylonas
Community Contributor
Little Green Pharma set to double revenue amidst European expansion
Forecasts for Growth, Future Revenue, Net Profit, and Key Metrics Forecasting LGP’s future performance involves assumptions based on FY2024 trends, market conditions, and strategic plans. Below are speculative projections for key metrics: Revenue Growth: FY2024 Baseline: $25.6 million, up 29% from $19.9 million in FY2023.
View narrative
AU$0.42
FV
70.8% undervalued
intrinsic discount
20.27%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
1
users have commented on this narrative
23
users have followed this narrative
3 months ago
author updated this narrative
Your Valuation for
LGP
LGP
Little Green Pharma
Your Fair Value
AU$
Current Price
AU$0.12
27.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-24m
72m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$72.4m
Earnings AU$6.5m
Advanced
Set Fair Value